RASKIN GREGORY S enters Y-MABS THERAPEUTICS, INC. with 5.88K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/20/2018ACC: 0001104659-18-057855
Director
Since Sep 2018
5.88K
Baseline shares
100% direct
5.88K
Direct ownership
1 position
68K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned5.88K
Total
5.88K direct5.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.88K | Direct |
| Total | 5.88K | 5.88K direct |
Derivative Holdings2
Non-Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
36K
Shares owned
N/A
Exercise price
4.38
Expiration
—
Exercise window
—
Non-Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
32K
Shares owned
N/A
Exercise price
11.16
Expiration
—
Exercise window
—
Total
Underlying
68K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Non-Employee Stock Option (right to buy) Direct | Common Stock | 4.38 | — | — | 36K | N/A |
| Non-Employee Stock Option (right to buy) Direct | Common Stock | 11.16 | — | — | 32K | N/A |
| Total | 68K | 0.00 | ||||